Video
23 Nov 2021

Boost your Drug Bioavailability with Labrafac™ MC60, Glycerol Monocaprylocaprate

This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. This session explores:

  • Using Lipid-based formulations to address oral bioavailability issues
  • Labrafac™ MC60, glycerol monocaprylocaprate, Gattefossé new bioehancer
  • Case study: step-by-step development of a lipid-based formulation of dutasteride with Labrafac™ MC60
  • Gattefossé technical expertise
  • Content provided by our supplier

    Gattefosse S.A.

    • FR
    • 2015
      On CPHI since
    Company types
    Manufacturer/Innovator

    Other Content from Gattefosse S.A. (2)